Renascience Inc.
4889・Growth Market・Pharmaceuticals
Governance
As a company with an Audit and Supervisory Committee, the board consists of 6 directors (of which 4 are outside directors, an outside ratio of approximately 67%). Outside directors hold a majority, and the company has established an Audit and Supervisory Committee, an executive officer system, and a Compliance Committee, achieving strengthened oversight functions and highly transparent management.
Risk Management
The company has established Compliance Regulations and Risk Management Regulations, and has set up a Compliance Committee that meets once every six months. Company-wide risk information is shared at weekly R&D meetings, and a system has been established to regularly report and manage risks, including sustainability-related risks, to the Board of Directors and the Management Committee.
Shareholder Returns
No dividend continues for both FY2026 (ending March 2026) and FY2027 (ending March 2027) forecasts (annual dividend of ¥0). No change to the policy of prioritizing securing funds for R&D. Share buyback of 10 shares (¥17 thousand) has been executed.
Dividend Policy
The company's policy is to prioritize securing funds in preparation for the continuous and planned execution of R&D activities, and not to pay dividends. The annual dividend was ¥0 for both FY2025 (ended March 2025) and FY2026 (ending March 2026). The forecast for FY2027 (ending March 2027) is also ¥0. Going forward, the company plans to consider distribution of surplus while taking into account its business performance and financial position.
ESG
Committed to contributing to the SDG goal of "Good Health and Well-Being for All," the company promotes solutions to social challenges through pharmaceutical development in the fields of cancer, anti-aging, and longevity. In terms of human resources, it has introduced flextime and remote work systems, achieved a female employee ratio of 33.3% (as of April 2026), and practices hiring and development policies that emphasize diversity.
Last updated: June 23, 2026